Editorial: Emerging Therapies for Malignant Mesothelioma by Nico van Zandwijk, Glen Reid, Paul Baas

Get full text

Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5. by Ngan Ching Cheng, Nico van Zandwijk, Glen Reid

Get full text

Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future by Glen Reid, Glen Reid, Thomas G. Johnson, Thomas G. Johnson, Thomas G. Johnson, Thomas G. Johnson, Nico van Zandwijk, Nico van Zandwijk

Get full text

The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy by Gerard J. Chu, Nico van Zandwijk, John E. J. Rasko

Get full text

Hitting the Bull’s-Eye: Mesothelin’s Role as a Biomarker and Therapeutic Target for Malignant Pleural Mesothelioma by Dannel Yeo, Laura Castelletti, Nico van Zandwijk, John E. J. Rasko

Get full text

Anti-Mesothelin CAR T cell therapy for malignant mesothelioma by Laura Castelletti, Dannel Yeo, Nico van Zandwijk, John E. J. Rasko

Get full text

The analysis of novel microRNA mimic sequences in cancer cells reveals lack of specificity in stem-loop RT-qPCR-based microRNA detection by Patrick Winata, Marissa Williams, Eileen McGowan, Najah Nassif, Nico van Zandwijk, Glen Reid

Get full text

Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972–2009 by Matthew J. Soeberg, Nicola Creighton, David C. Currow, Jane M. Young, Nico van Zandwijk

Get full text

MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients by Ruby C.Y. Lin, Michaela B. Kirschner, Yuen Yee Cheng, Nico van Zandwijk, Glen Reid

Get full text

Covalent binding of molecules to plasma immersion ion implantation‐activated microparticles for delivery into cells by Hedi V. Kruse, Clara T. H. Tran, Nico vanZandwijk, Natalka Suchowerska, David R. McKenzie, Glen Reid

Get full text

A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma by Karin Schelch, Michaela B. Kirschner, Marissa Williams, Yuen Y. Cheng, Nico vanZandwijk, Michael Grusch, Glen Reid

Get full text

Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma by Xiyong Fan, Chris McLaughlin, Cleo Robinson, Jason Ravasini, Karin Schelch, Thomas Johnson, Nico vanZandwijk, Glen Reid, Anthony M. George

Get full text

Exon 20-Mutated NSCLC: Extending the Data Set to Allow the Recognition of Potential Causes by Nico van Zandwijk, PhD, MD, FRACP, FCCP, Christopher I. Amos, PhD, Oluf Dimitri Røe, MD, PhD, Glen Reid, PhD, Sonja Klebe, MD, PhD, FRCPA, FFSc

Get full text

Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM). by Casey M Wright, Michaela B Kirschner, Yuen Yee Cheng, Kenneth J O'Byrne, Steven G Gray, Karin Schelch, Mir Alireza Hoda, Sonja Klebe, Brian McCaughan, Nico van Zandwijk, Glen Reid

Get full text

Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. by Mariëlle I Gallegos Ruiz, Karijn Floor, Paul Roepman, José A Rodriguez, Gerrit A Meijer, Wolter J Mooi, Ewa Jassem, Jacek Niklinski, Thomas Muley, Nico van Zandwijk, Egbert F Smit, Kristin Beebe, Len Neckers, Bauke Ylstra, Giuseppe Giaccone

Get full text